MVIS US Listed Biotech 25 Index ETF Overview

With 1 ETF traded in the U.S. markets, MVIS US Listed Biotech 25 Index ETF gathers total assets under management of $403.69M. The average expense ratio is 0.35%. MVIS US Listed Biotech 25 Index ETF can be found in the following asset class:

  • Equity Analysis

Finding The Best Biotech ETF

It's easy to be blinded by headline numbers. The rally in biotech isn't so simple.

Daily ETF Watch

Daily ETF Watch: Institutional Use Grows

ETFs are becoming core holdings for institutions.

Features and News

5 High-Flying 2013 Niche ETF Sectors

High-flying ETFs in several sectors eclipsed the S&P 500 gains.

Features and News

Biotech ETF Among 2013 Best Performers

Multiple factors are setting the sector up for further growth in 2014.

Features and News

Best ETFs In 2013: DBJP, Tesla-Fueled QCLN

The latest tally of year-to-date top-10-performing ETFs include Japan, clean energy and biotech funds, to name a few. Analysis

EGPT And Beyond: 2012’s Top ETFs So Far

Who knew Egypt would be the best ETF as the third quarter draws to a close?